Skip to content

   Pharma Publications

Neuropsychopharmacology
  • In Memorium: Robert Bruce Lydiard, Ph.D., M.D.
    Published on 2026-09-08
    5 days ago
  • Psilocybin as an emerging anxiolytic: mechanisms, evidence, and open questions
    Published on 2026-09-06
    7 days ago
  • Menstrual cycle-dependent white matter microstructural dynamics in women with substance use disorder
    Published on 2026-09-05
    1 week ago
  • NMDA subunit 2B-selective negative allosteric modulator satoprodil (BI 1569912) as mono- and adjunctive therapy in patients with major depressive disorder: results from two phase 2 randomized, controlled trials
    Published on 2026-09-05
    1 week ago
  • Complex social dominance behavior using a novel platform test is associated with lateral habenula activation in male and female mice
    Published on 2026-09-04
    1 week ago
  • Correction: Shared genetic architecture and neurobiological pathways of problematic alcohol use and anxiety disorders
    Published on 2026-09-04
    1 week ago
  • NMDA receptor ablation in medial prefrontal cortex disrupts value updating and reward history integration
    Published on 2026-09-01
    2 weeks ago
« Previous 1 2 3 4 … 143 Next »
Journal of Psychopharmacology
  • Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice
    Published on 2026-08-31
    2 weeks ago
  • Pharmacokinetics, pharmacodynamics and safety of N,N-dimethyltryptamine administered intravenously in healthy smoking and non-smoking volunteers
    Published on 2026-08-31
    2 weeks ago
  • A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin
    Published on 2026-08-30
    2 weeks ago
  • Oregon’s state-regulated psilocybin services: Early real-world safety signals
    Published on 2026-08-29
    2 weeks ago
  • Beyond head-twitch response: Acute psilocybin affects spontaneous behaviors in rats in a dose-dependent manner
    Published on 2026-08-25
    3 weeks ago
  • Dopaminergic fronto-striatal connectivity underlies schema-dependent learning
    Published on 2026-08-25
    3 weeks ago
  • Benzodiazepines and GABAA receptor subtypes: Effects in open-field, elevated plus maze-discriminative avoidance task, and conditioned place preference in male mice
    Published on 2026-08-25
    3 weeks ago
« Previous 1 2 3 4 … 154 Next »
European Neuropsychopharmacology
  • Global patterns of clozapine prescribing: An international comparison of prescribing indications across 15 regions
    Published on 2026-08-22
    3 weeks ago
  • Cognitive reserve beyond ageing and dementia: A framework for early psychosis prevention and intervention
    Published on 2026-08-17
    4 weeks ago
  • Corrigendum to “T70. Genetics of treatment resistant depression in Pakistan; update from the DIVERGE study” [European Neuropsychopharmacology 87, Supplement 1 (2024) 191]
    Published on 2026-08-08
    1 month ago
  • The impact of anhedonia on physical health and somatic diseases: an exploratory literature review
    Published on 2026-07-20
    2 months ago
  • Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report
    Published on 2026-07-18
    2 months ago
  • Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour
    Published on 2026-07-18
    2 months ago
  • The multivariate genetic architecture of psychiatric and insulin resistance multimorbidity
    Published on 2026-07-12
    2 months ago
« Previous 1 2 3 4 … 170 Next »

   Pharma Pub